Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

The requested reference [d6ba80187d06656362e4544bfe43e58cc50878b8] no longer exists in our database. It has been replaced by the current reference: [b0a8a94f1620dcd6b184e40428e1d5ed76a3776c]

Authors Cerebral Therapeutics LLC -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Links ClinicalTrials.gov
This is a Phase 2 double-blind, randomized, placebo-controlled study to assess the safety and efficacy of ICV delivery of CT-010 via an implantable pump and a cranial port and dual lumen catheter (CIC) in subjects with focal seizures, with temporal lobe onset with or without secondary generalization. Up to 70 subjects will be enrolled. Eligible subjects will be randomized in a 1:1 ratio to either CT-010 or placebo treatment. Up to 20 clinical centers will be enrolled.
Epistemonikos ID: c11ed33066cf1e054ab1fa78c87b0974af70a102
First added on: May 06, 2024